Doxorubicin (Capsulution Pharma)

N/A

Report date: 2026/01/26 13:50:15

Base Information

Drug NameDoxorubicin (Capsulution Pharma)
Drug Alias NameDoxorubicinDoxorubicin (NanoDel)
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics
Mechanisms of ActionVirus DNA polymerase inhibitorsDNA intercalatorsTopoisomerase II inhibitors
TargetsTopoisomerase IIDNAVirus DNA polymerase
Therapy Area/IndicationsBrain Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNanoDel Technologies GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCapsulution Pharma AGNanoDel Technologies GmbH
Active IndicationsN/A
Inactive IndicationsBrain Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A